CD14	B-protein
-mediated	O
signal	O
pathway	O
of	O
Porphyromonas	O
gingivalis	O
lipopolysaccharide	O
in	O
human	B-cell_type
gingival	I-cell_type
fibroblasts	I-cell_type
.	O

Lipopolysaccharide	O
(	O
LPS	O
)	O
induces	O
expression	O
of	O
inflammatory	B-protein
cytokines	I-protein
in	O
monocytes/macrophages	B-cell_type
via	O
CD14	B-protein
,	O
one	O
of	O
the	O
LPS	B-protein
receptors	I-protein
,	O
which	O
is	O
expressed	O
predominantly	O
in	O
these	O
cells	O
.	O

It	O
has	O
been	O
demonstrated	O
that	O
Porphyromonas	O
gingivalis	O
LPS	O
(	O
P-LPS	O
)	O
also	O
is	O
able	O
to	O
induce	O
inflammatory	B-protein
cytokines	I-protein
in	O
human	B-cell_type
gingival	I-cell_type
fibroblasts	I-cell_type
.	O

Therefore	O
,	O
it	O
is	O
important	O
to	O
determine	O
whether	O
CD14	B-protein
is	O
expressed	O
in	O
gingival	B-cell_type
fibroblasts	I-cell_type
and	O
to	O
define	O
the	O
P-LPS-mediated	O
signal-transducing	B-protein
mechanism	O
in	O
the	O
cells	O
.	O

In	O
this	O
study	O
,	O
we	O
observed	O
unexpectedly	O
by	O
immunohistochemical	O
,	O
Western	O
blotting	O
(	O
immunoblotting	O
)	O
,	O
and	O
Northern	O
(	O
RNA	O
)	O
blotting	O
assays	O
that	O
CD14	B-protein
is	O
expressed	O
at	O
high	O
density	O
in	O
human	B-cell_type
gingival	I-cell_type
fibroblasts	I-cell_type
.	O

P-LPS-induced	O
expression	O
of	O
the	O
monocyte	B-DNA
chemoattractant	I-DNA
protein	I-DNA
1	I-DNA
(	I-DNA
MCP-1	I-DNA
)	I-DNA
gene	I-DNA
in	O
the	O
cells	O
was	O
inhibited	O
markedly	O
by	O
treatment	O
with	O
anti-human	O
CD14	B-protein
antibody	O
and	O
was	O
completely	O
inhibited	O
by	O
herbimycin	O
A	O
,	O
a	O
potent	O
inhibitor	O
of	O
tyrosine	B-protein
kinase	I-protein
.	O

The	O
inhibitor	O
also	O
dramatically	O
inhibited	O
monocyte	O
chemotactic	O
activity	O
of	O
and	O
MCP-1	B-protein
production	O
by	O
the	O
cells	O
.	O

Furthermore	O
,	O
P-LPS-induced	O
expression	O
of	O
the	O
MCP-1	B-DNA
gene	I-DNA
in	O
the	O
cells	O
also	O
was	O
blocked	O
by	O
inhibitors	O
of	O
two	O
transcription	B-protein
factors	I-protein
,	O
i.e.	O
,	O
curcumin	O
,	O
an	O
inhibitor	O
of	O
AP-1	B-protein
,	O
and	O
pyrolidine	O
dithiocarbamate	O
,	O
an	O
inhibitor	O
of	O
NF-kappaB	B-protein
.	O

Both	O
inhibitors	O
inhibited	O
monocyte	O
chemotactic	O
activity	O
in	O
the	O
culture	O
supernatant	O
of	O
P-LPS-treated	O
cells	O
.	O

Gel	O
shift	O
mobility	O
assay	O
showed	O
stimulation	O
of	O
the	O
AP-1	B-protein
and	O
NF-kappaB	B-protein
contents	O
in	O
P-LPS-treated	O
cells	O
.	O

This	O
study	O
is	O
the	O
first	O
to	O
demonstrate	O
the	O
expression	O
of	O
CD14	B-protein
in	O
human	B-cell_type
gingival	I-cell_type
fibroblasts	I-cell_type
and	O
to	O
show	O
that	O
the	O
signal-transducing	O
pathway	O
of	O
P-LPS	O
in	O
the	O
cells	O
is	O
mediated	O
by	O
CD14	B-protein
.	O

INFECTION	NULL
AND	NULL
IMMUNITY	NULL
,	NULL
Nov.	NULL
1996	NULL
,	NULL
p.	NULL
4488-4494	NULL
0019-9567/96/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
Â©	NULL
1996	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

64	NULL
,	NULL
No	NULL
.	NULL

11	NULL
CD14-Mediated	NULL
Signal	NULL
Pathway	NULL
of	NULL
Porphyromonas	NULL
gingivalis	NULL
Lipopolysaccharide	NULL
in	NULL
Human	NULL
Gingival	NULL
Fibroblasts	NULL
ATSUSHI	NULL
WATANABE	NULL
,	NULL
AKIRA	NULL
TAKESHITA	NULL
,	NULL
SHIGEO	NULL
KITANO	NULL
,	NULL
anp	NULL
SHIGEMASA	NULL
HANAZAWA*	NULL
Department	NULL
of	NULL
Oral	NULL
Microbiology	NULL
,	NULL
Meikai	NULL
University	NULL
School	NULL
of	NULL
Dentistry	NULL
,	NULL
Keyakidai	NULL
1-1	NULL
,	NULL
Sakado	NULL
City	NULL
,	NULL
Saitama	NULL
350-02	NULL
,	NULL
Japan	NULL
Received	NULL
25	NULL
March	NULL
1996/Returned	NULL
for	NULL
modification	NULL
17	NULL
May	NULL
1996/Accepted	NULL
7	NULL
August	NULL
1996	NULL
Lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
induces	NULL
expression	NULL
of	NULL
inflammatory	NULL
cytokines	NULL
in	NULL
monocytes/macrophages	NULL
via	NULL
CD14	NULL
,	NULL
one	NULL
of	NULL
the	NULL
LPS	NULL
receptors	NULL
,	NULL
which	NULL
is	NULL
expressed	NULL
predominantly	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

It	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
Porphyromonas	NULL
gingivalis	NULL
LPS	NULL
(	NULL
P-LPS	NULL
)	NULL
also	NULL
is	NULL
able	NULL
to	NULL
induce	NULL
inflammatory	NULL
cytokines	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
determine	NULL
whether	NULL
CD14	NULL
is	NULL
expressed	NULL
in	NULL
gingival	NULL
fibroblasts	NULL
and	NULL
to	NULL
define	NULL
the	NULL
P-LPS-mediated	NULL
signal-transducing	NULL
mechanism	NULL
in	NULL
the	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
observed	NULL
unexpectedly	NULL
by	NULL
immunohistochemical	NULL
,	NULL
Western	NULL
blotting	NULL
(	NULL
immunoblotting	NULL
)	NULL
,	NULL
and	NULL
Northern	NULL
(	NULL
RNA	NULL
)	NULL
blotting	NULL
assays	NULL
that	NULL
CD14	NULL
is	NULL
expressed	NULL
at	NULL
high	NULL
density	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

P-LPS-induced	NULL
expression	NULL
of	NULL
the	NULL
monocyte	NULL
chemoattractant	NULL
protein	NULL
1	NULL
(	NULL
MCP-1	NULL
)	NULL
gene	NULL
in	NULL
the	NULL
cells	NULL
was	NULL
inhibited	NULL
markedly	NULL
by	NULL
treatment	NULL
with	NULL
anti-human	NULL
CD14	NULL
antibody	NULL
and	NULL
was	NULL
completely	NULL
was	NULL
inhibited	NULL
by	NULL
herbimycin	NULL
A	NULL
,	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
tyrosine	NULL
kinase	NULL
.	NULL

The	NULL
inhibitor	NULL
also	NULL
dramatically	NULL
inhibited	NULL
monocyte	NULL
chemotactic	NULL
activity	NULL
of	NULL
and	NULL
MCP-1	NULL
production	NULL
by	NULL
the	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
P-LPS-induced	NULL
expression	NULL
of	NULL
the	NULL
MCP	NULL
gene	NULL
in	NULL
the	NULL
cells	NULL
also	NULL
was	NULL
blocked	NULL
by	NULL
inhibitors	NULL
of	NULL
two	NULL
transcription	NULL
factors	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
curcumin	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
AP-1	NULL
,	NULL
and	NULL
pyrolidine	NULL
dithiocarbamate	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
NF-KB	NULL
.	NULL

Both	NULL
inhibitors	NULL
inhibited	NULL
monocyte	NULL
chemotactic	NULL
activity	NULL
in	NULL
the	NULL
culture	NULL
supernatant	NULL
of	NULL
P-LPS-treated	NULL
cells	NULL
.	NULL

Gel	NULL
shift	NULL
mobility	NULL
assay	NULL
showed	NULL
stimulation	NULL
of	NULL
the	NULL
AP-1	NULL
and	NULL
NF-B	NULL
contents	NULL
in	NULL
P-LPS-treated	NULL
cells	NULL
.	NULL

This	NULL
study	NULL
is	NULL
the	NULL
first	NULL
to	NULL
demonstrate	NULL
the	NULL
expression	NULL
of	NULL
CD14	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
and	NULL
to	NULL
show	NULL
that	NULL
the	NULL
signal-trans-	NULL
ducing	NULL
pathway	NULL
of	NULL
P-LPS	NULL
in	NULL
the	NULL
cells	NULL
is	NULL
mediated	NULL
by	NULL
CD14	NULL
.	NULL

Lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
of	NULL
Porphyromonas	NULL
gingivalis	NULL
,	NULL
a	NULL
pathogenic	NULL
bacterium	NULL
of	NULL
periodontal	NULL
disease	NULL
,	NULL
has	NULL
been	NULL
considered	NULL
an	NULL
important	NULL
pathogenic	NULL
component	NULL
of	NULL
the	NULL
organism	NULL
in	NULL
the	NULL
initiation	NULL
and	NULL
development	NULL
of	NULL
periodontal	NULL
diseases	NULL
,	NULL
because	NULL
bacterial	NULL
LPS	NULL
is	NULL
known	NULL
to	NULL
be	NULL
a	NULL
potent	NULL
stimulator	NULL
of	NULL
inflammatory	NULL
cytokine	NULL
production	NULL
and	NULL
bone	NULL
resorption	NULL
(	NULL
2	NULL
,	NULL
12	NULL
,	NULL
18	NULL
,	NULL
21	NULL
,	NULL
31	NULL
)	NULL
.	NULL

One	NULL
target	NULL
of	NULL
LPS	NULL
is	NULL
the	NULL
human	NULL
gingival	NULL
fibroblast	NULL
,	NULL
a	NULL
cell	NULL
that	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
remodeling	NULL
of	NULL
periodontal	NULL
soft	NULL
tissues	NULL
.	NULL

These	NULL
fibroblasts	NULL
may	NULL
also	NULL
function	NULL
as	NULL
a	NULL
regulator	NULL
of	NULL
the	NULL
cytokine	NULL
network	NULL
of	NULL
periodontal	NULL
tissues	NULL
,	NULL
because	NULL
they	NULL
produce	NULL
several	NULL
kinds	NULL
of	NULL
cytokine	NULL
when	NULL
stimulated	NULL
by	NULL
inflammatory	NULL
cytokines	NULL
and	NULL
bacterial	NULL
cell	NULL
components	NULL
.	NULL

Several	NULL
studies	NULL
(	NULL
18	NULL
,	NULL
33	NULL
,	NULL
35	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
P.	NULL
gingivalis	NULL
LPS	NULL
(	NULL
P-LPS	NULL
)	NULL
stimulates	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
IL-6	NULL
production	NULL
by	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

Other	NULL
studies	NULL
(	NULL
37	NULL
,	NULL
42	NULL
)	NULL
have	NULL
demonstrated	NULL
that	NULL
CD14	NULL
,	NULL
one	NULL
of	NULL
the	NULL
LPS	NULL
receptors	NULL
,	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
signal	NULL
transduction	NULL
in	NULL
the	NULL
LPS-responsive	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
well	NULL
known	NULL
that	NULL
a	NULL
high	NULL
expression	NULL
of	NULL
CD14	NULL
is	NULL
found	NULL
predominantly	NULL
on	NULL
monocytes/macrophages	NULL
and	NULL
neutrophils	NULL
.	NULL

However	NULL
,	NULL
more	NULL
recently	NULL
,	NULL
an	NULL
interesting	NULL
study	NULL
(	NULL
10	NULL
)	NULL
has	NULL
demonstrated	NULL
that	NULL
CD14	NULL
gene	NULL
expression	NULL
in	NULL
the	NULL
mouse	NULL
is	NULL
not	NULL
restricted	NULL
to	NULL
myeloid	NULL
cells	NULL
but	NULL
also	NULL
occurs	NULL
in	NULL
epithelial	NULL
cells	NULL
of	NULL
various	NULL
organs	NULL
.	NULL

This	NULL
demonstration	NULL
suggested	NULL
to	NULL
us	NULL
that	NULL
LPS	NULL
may	NULL
be	NULL
involved	NULL
actively	NULL
in	NULL
inflammatory	NULL
reactions	NULL
of	NULL
various	NULL
tissues	NULL
via	NULL
CD14	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
examine	NULL
whether	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
express	NULL
CD14	NULL
on	NULL
their	NULL
cell	NULL
sur-face	NULL
.	NULL

If	NULL
they	NULL
do	NULL
,	NULL
it	NULL
would	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
elucidate	NULL
the	NULL
CD14-mediated	NULL
signal	NULL
transducing	NULL
mechanism	NULL
of	NULL
P-LPS	NULL
in	NULL
these	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
show	NULL
that	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
ex	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Oral	NULL
Microbiology	NULL
,	NULL
Meikai	NULL
University	NULL
School	NULL
of	NULL
Dentistry	NULL
,	NULL
Keyakidai	NULL
1-1	NULL
,	NULL
Sakado	NULL
City	NULL
,	NULL
Saitama	NULL
350-02	NULL
,	NULL
Japan	NULL
.	NULL

Fax	NULL
:	NULL
492-853-1035	NULL
.	NULL

4488	NULL
press	NULL
CD14	NULL
and	NULL
also	NULL
demonstrate	NULL
CD14	NULL
mediation	NULL
of	NULL
the	NULL
signal	NULL
pathway	NULL
of	NULL
P-LPS	NULL
in	NULL
the	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents	NULL
.	NULL

Alpha	NULL
minimal	NULL
essential	NULL
medium	NULL
(	NULL
Â«	NULL
-MEM	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Flow	NULL
Laboratories	NULL
(	NULL
McLean	NULL
,	NULL
Va.	NULL
)	NULL
,	NULL
methionine-free	NULL
Eagle	NULL
's	NULL
MEM	NULL
was	NULL
obtained	NULL
from	NULL
Nissui	NULL
Pharmaceutical	NULL
Co.	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
and	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
HyClone	NULL
(	NULL
Logan	NULL
,	NULL
Utah	NULL
)	NULL
.	NULL

5'-	NULL
[	NULL
Â«	NULL
-P	NULL
]	NULL
dCTP	NULL
,	NULL
a	NULL
multiprime	NULL
DNA	NULL
labeling	NULL
system	NULL
,	NULL
***I-labeled	NULL
protein	NULL
A	NULL
,	NULL
and	NULL
[	NULL
``	NULL
Â°S	NULL
}	NULL
methionine	NULL
(	NULL
15	NULL
mCi/ml	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Amersham	NULL
Japan	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Protein	NULL
A-Sepharose	NULL
beads	NULL
were	NULL
from	NULL
Pharmacia-LKB	NULL
Japan	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

A	NULL
kit	NULL
of	NULL
avidin-biotin-alkaline	NULL
phosphatase-conjugated	NULL
mouse	NULL
immunoglobulin	NULL
G	NULL
(	NULL
IgG	NULL
;	NULL
Histofine	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Nichirei	NULL
Co.	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Anti-monocyte	NULL
chemoattractant	NULL
protein	NULL
1	NULL
(	NULL
MCP-1	NULL
)	NULL
antiserum	NULL
was	NULL
from	NULL
Genzyme	NULL
(	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

,	NULL
and	NULL
anti-human	NULL
CD14	NULL
antibody	NULL
from	NULL
clone	NULL
RMO	NULL
52	NULL
was	NULL
from	NULL
Cosmo	NULL
Bio	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Formyl-methionyl-leucine-phenylalanine	NULL
,	NULL
herbimycin	NULL
A	NULL
,	NULL
staurosporine	NULL
,	NULL
pyrolidine	NULL
dithiocarbamate	NULL
(	NULL
PDTC	NULL
)	NULL
,	NULL
curcumin	NULL
,	NULL
and	NULL
Escherichia	NULL
coli	NULL
O111	NULL
B4-derived	NULL
LPS	NULL
were	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

;	NULL
H-7	NULL
and	NULL
H-89	NULL
were	NULL
from	NULL
Seikagaku	NULL
Kougyo	NULL
Co.	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

P-LPS	NULL
.	NULL

P-LPS	NULL
was	NULL
provided	NULL
by	NULL
T.	NULL
Umemoto	NULL
(	NULL
Kanagawa	NULL
Dental	NULL
College	NULL
)	NULL
.	NULL

The	NULL
procedure	NULL
for	NULL
LPS	NULL
preparation	NULL
was	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Briefly	NULL
the	NULL
LPS	NULL
was	NULL
extracted	NULL
from	NULL
acetone-dried	NULL
cells	NULL
by	NULL
the	NULL
phenol-water	NULL
method	NULL
and	NULL
then	NULL
purified	NULL
by	NULL
repeated	NULL
ultracentrifugation	NULL
six	NULL
times	NULL
at	NULL
105,000	NULL
x	NULL
g	NULL
for	NULL
16	NULL
h	NULL
and	NULL
RNase	NULL
treatment	NULL
.	NULL

Culture	NULL
of	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

Human	NULL
gingival	NULL
fibroblasts	NULL
were	NULL
prepared	NULL
from	NULL
explants	NULL
of	NULL
human	NULL
normal	NULL
gingival	NULL
tissues	NULL
.	NULL

The	NULL
explants	NULL
were	NULL
cultured	NULL
in	NULL
30-mm-diameter	NULL
Falcon	NULL
plastic	NULL
dishes	NULL
with	NULL
Â«	NULL
-MEM	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
under	NULL
an	NULL
atmosphere	NULL
of	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
at	NULL
37Â°C	NULL
.	NULL

After	NULL
a	NULL
confluent	NULL
monolayer	NULL
of	NULL
the	NULL
migrating	NULL
cells	NULL
had	NULL
formed	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
passaged	NULL
by	NULL
trypsinization	NULL
and	NULL
then	NULL
again	NULL
grown	NULL
to	NULL
confluence	NULL
in	NULL
90-mm-diameter	NULL
plastic	NULL
dishes	NULL
.	NULL

After	NULL
the	NULL
fifth	NULL
passage	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
typical	NULL
homogeneous	NULL
fibroblasts	NULL
with	NULL
a	NULL
spindle	NULL
shape	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
this	NULL
study	NULL
,	NULL
we	NULL
used	NULL
the	NULL
gingival	NULL
fibroblasts	NULL
between	NULL
passages	NULL
6	NULL
and	NULL
10	NULL
.	NULL

The	NULL
cell	NULL
responsiveness	NULL
to	NULL
P-LPS	NULL
was	NULL
demonstrated	NULL
previously	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Western	NULL
blotting	NULL
(	NULL
immunoblotting	NULL
)	NULL
analysis	NULL
.	NULL

Human	NULL
gingival	NULL
fibroblasts	NULL
(	NULL
10	NULL
``	NULL
cells	NULL
)	NULL
were	NULL
solubilized	NULL
with	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
1	NULL
%	NULL
sodium	NULL
de-oxycholate	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
0.1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
[	NULL
SDS	NULL
]	NULL
,	NULL
20	NULL
mM	NULL
EDTA	NULL
,	NULL
0.25	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
[	NULL
PMSF	NULL
]	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
)	NULL
.	NULL

The	NULL
samples	NULL
(	NULL
50	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
were	NULL
electrophoresed	NULL
on	NULL
10	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
,	NULL
using	NULL
a	NULL
Tris-glycine	NULL
buffer	NULL
system	NULL
(	NULL
0.025	NULL
M	NULL
Tris	NULL
,	NULL
0.192	NULL
M	NULL
glycine	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
was	NULL
transferred	NULL
to	NULL
a	NULL
polyvinylidene	NULL
difluoride	NULL
membrane	NULL
(	NULL
Millipore	NULL
Corp.	NULL
,	NULL
Bedford	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

by	NULL
use	NULL
of	NULL
a	NULL
semidry	NULL
transblot	NULL
system	NULL
(	NULL
ATTO	NULL
Co.	NULL
,	NULL
Tokyo	NULL
,	NULL
VoL	NULL
.	NULL

64	NULL
,	NULL
1996	NULL
CD14-MEDIATED	NULL
SIGNAL	NULL
IN	NULL
GINGIVAL	NULL
FIBROBLASTS	NULL
4489	NULL
A	NULL
D	NULL
F	NULL
(	NULL
K	NULL
Da	NULL
)	NULL
220	NULL
--	NULL
>	NULL
Â»	NULL
97.4	NULL
-	NULL
>	NULL
Â»	NULL
|	NULL
CDial	NULL
#	NULL
|n4kbp	NULL
_	NULL
;	NULL
,	NULL
__	NULL
y	NULL
â	NULL
B	NULL
/	NULL
``	NULL
``	NULL
A	NULL
]	NULL
â¬	NULL
Actin	NULL
|	NULL
WP	NULL
46	NULL
>	NULL
~	NULL
g	NULL
21.5	NULL
-*	NULL
]	NULL
_-1	NULL
2	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Expression	NULL
of	NULL
CD14	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

Acetone-fixed	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
normal	NULL
mouse	NULL
IgG	NULL
(	NULL
A	NULL
)	NULL
or	NULL
anti-human	NULL
CD14	NULL
antibody	NULL
(	NULL
B	NULL
)	NULL
and	NULL
then	NULL
reacted	NULL
with	NULL
horseradish-conjugated	NULL
anti-mouse	NULL
IgG	NULL
antibody	NULL
.	NULL

In	NULL
another	NULL
experiment	NULL
(	NULL
C	NULL
)	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
gingival	NULL
fibroblasts	NULL
incubated	NULL
under	NULL
serum-free	NULL
conditions	NULL
,	NULL
and	NULL
Northern	NULL
blotting	NULL
analysis	NULL
was	NULL
performed	NULL
with	NULL
mouse	NULL
CD14	NULL
and	NULL
B-actin	NULL
cDNAs	NULL
used	NULL
as	NULL
probes	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Western	NULL
blotting	NULL
analysis	NULL
using	NULL
anti-human	NULL
CD14	NULL
antibody	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
normal	NULL
mouse	NULL
IgG	NULL
as	NULL
a	NULL
control	NULL
antibody	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
was	NULL
conducted	NULL
to	NULL
test	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
CD14	NULL
in	NULL
the	NULL
cells	NULL
(	NULL
D	NULL
)	NULL
.	NULL

An	NULL
identical	NULL
Western	NULL
blot	NULL
experiment	NULL
independently	NULL
performed	NULL
gave	NULL
similar	NULL
results	NULL
.	NULL

Japan	NULL
)	NULL
.	NULL

Blots	NULL
were	NULL
blocked	NULL
with	NULL
2	NULL
%	NULL
skim	NULL
milk	NULL
in	NULL
Tris-buffered	NULL
saline	NULL
(	NULL
TBS	NULL
)	NULL
(	NULL
100	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
)	NULL
containing	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
for	NULL
6	NULL
h	NULL
and	NULL
washed	NULL
with	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
in	NULL
TBS	NULL
.	NULL

Then	NULL
the	NULL
membrane	NULL
was	NULL
incubated	NULL
for	NULL
12	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
anti-human	NULL
CD14	NULL
antibody	NULL
(	NULL
1:100	NULL
)	NULL
or	NULL
normal	NULL
mouse	NULL
IgG	NULL
(	NULL
1:100	NULL
)	NULL
in	NULL
TBS	NULL
and	NULL
washed	NULL
twice	NULL
with	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
in	NULL
TBS	NULL
.	NULL

The	NULL
washed	NULL
membrane	NULL
was	NULL
treated	NULL
for	NULL
3	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
2	NULL
Ci	NULL
of	NULL
***I-labeled	NULL
protein	NULL
A	NULL
per	NULL
ml	NULL
and	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
in	NULL
TBS	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
X-Omat	NULL
film	NULL
(	NULL
Eastman	NULL
Kodak	NULL
Co.	NULL
)	NULL
.	NULL

Immunohistochemistry	NULL
.	NULL

Immunostaining	NULL
was	NULL
performed	NULL
on	NULL
acetone-fixed	NULL
smears	NULL
of	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

The	NULL
fixed	NULL
smears	NULL
were	NULL
treated	NULL
for	NULL
10	NULL
min	NULL
with	NULL
10	NULL
%	NULL
normal	NULL
rabbit	NULL
serum	NULL
,	NULL
washed	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
,	NULL
incubated	NULL
overnight	NULL
at	NULL
4Â°C	NULL
with	NULL
anti-human	NULL
CD14	NULL
monoclonal	NULL
antibody	NULL
(	NULL
1:100	NULL
)	NULL
or	NULL
normal	NULL
mouse	NULL
IgG	NULL
(	NULL
1:100	NULL
)	NULL
as	NULL
a	NULL
control	NULL
antibody	NULL
,	NULL
and	NULL
washed	NULL
;	NULL
thereafter	NULL
the	NULL
immunohistological	NULL
reaction	NULL
was	NULL
detected	NULL
with	NULL
a	NULL
kit	NULL
of	NULL
avidin-biotin-alkaline	NULL
phosphatase-conjugated	NULL
mouse	NULL
IgG	NULL
as	NULL
instructed	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

cDNA	NULL
hybridization	NULL
probe	NULL
.	NULL

Plasmids	NULL
containing	NULL
human	NULL
MCP-1	NULL
sequences	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
B.	NULL
J.	NULL
Rollins	NULL
)	NULL
,	NULL
mouse	NULL
CD14	NULL
sequence	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
S.	NULL
Yamamoto	NULL
)	NULL
,	NULL
and	NULL
B-actin	NULL
sequences	NULL
(	NULL
Oncor	NULL
Co.	NULL
,	NULL
Gaithersburg	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

were	NULL
prepared	NULL
as	NULL
described	NULL
earlier	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
total	NULL
RNA	NULL
and	NULL
Northern	NULL
(	NULL
RNA	NULL
)	NULL
blot	NULL
analysis	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
Â«	NULL
-MEM	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
in	NULL
Falcon	NULL
90-mm-diameter	NULL
plastic	NULL
plates	NULL
until	NULL
nearly	NULL
confluent	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
,	NULL
incubated	NULL
for	NULL
24	NULL
h	NULL
in	NULL
serum-free	NULL
-MEM	NULL
,	NULL
and	NULL
subsequently	NULL
treated	NULL
for	NULL
the	NULL
desired	NULL
periods	NULL
in	NULL
serum-free	NULL
e-MEM	NULL
with	NULL
or	NULL
without	NULL
test	NULL
samples	NULL
at	NULL
various	NULL
concentrations	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
in	NULL
the	NULL
cells	NULL
was	NULL
extracted	NULL
by	NULL
the	NULL
guanidine	NULL
isothiocyanate	NULL
procedure	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Gene	NULL
expression	NULL
was	NULL
analyzed	NULL
by	NULL
Northern	NULL
blot	NULL
assay	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
19	NULL
)	NULL
.	NULL

B-Actin	NULL
was	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
standard	NULL
for	NULL
quantification	NULL
of	NULL
total	NULL
mRNA	NULL
on	NULL
each	NULL
lane	NULL
of	NULL
the	NULL
gel	NULL
.	NULL

Monocyte	NULL
chemotactic	NULL
assay	NULL
.	NULL

The	NULL
monocyte	NULL
chemotactic	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
by	NULL
centrifugation	NULL
on	NULL
Ficoll-Hypaque	NULL
(	NULL
Pharmacia	NULL
Japan	NULL
)	NULL
and	NULL
used	NULL
for	NULL
the	NULL
chemotaxis	NULL
assay	NULL
in	NULL
a	NULL
48-well	NULL
apparatus	NULL
equipped	NULL
with	NULL
a	NULL
5-m-pore-size	NULL
polycarbonate	NULL
filter	NULL
(	NULL
Nuclepore	NULL
;	NULL
Costar	NULL
Corp.	NULL
,	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

.	NULL

Monocytes	NULL
that	NULL
had	NULL
migrated	NULL
through	NULL
the	NULL
filter	NULL
onto	NULL
its	NULL
bottom	NULL
side	NULL
were	NULL
counted	NULL
in	NULL
20	NULL
microgrid	NULL
fields	NULL
under	NULL
oil	NULL
immersion	NULL
(	NULL
magnification	NULL
,	NULL
1,000	NULL
)	NULL
,	NULL
and	NULL
then	NULL
the	NULL
total	NULL
count	NULL
was	NULL
divided	NULL
by	NULL
20	NULL
.	NULL

The	NULL
chemotactic	NULL
activity	NULL
was	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
standard	NULL
deviation	NULL
of	NULL
the	NULL
total	NULL
number	NULL
of	NULL
migrating	NULL
monocytes	NULL
per	NULL
oil	NULL
immersion	NULL
field	NULL
in	NULL
triplicate	NULL
assays	NULL
.	NULL

Formyl-methionyl-leucine-phenylalanine	NULL
at	NULL
10~Â®	NULL
M	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

Metabolic	NULL
labeling	NULL
and	NULL
i	NULL
precipitation	NULL
assay	NULL
.	NULL

Subconfluent	NULL
monolayers	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
,	NULL
treated	NULL
or	NULL
not	NULL
with	NULL
test	NULL
samples	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
24	NULL
h	NULL
in	NULL
methionine-free	NULL
Eagle	NULL
's	NULL
MEM	NULL
containing	NULL
(	NULL
350	NULL
pCi/ml	NULL
)	NULL
.	NULL

The	NULL
culture	NULL
supernatants	NULL
(	NULL
500	NULL
pl	NULL
)	NULL
were	NULL
supplemented	NULL
with	NULL
Triton	NULL
X	NULL
100	NULL
(	NULL
1	NULL
%	NULL
)	NULL
,	NULL
EDTA	NULL
(	NULL
1	NULL
mM	NULL
)	NULL
,	NULL
and	NULL
protease	NULL
inhibitors	NULL
(	NULL
PMSF	NULL
[	NULL
0.8	NULL
mM	NULL
]	NULL
and	NULL
leupeptin	NULL
[	NULL
10	NULL
ug/tml	NULL
]	NULL
)	NULL
.	NULL

Each	NULL
sample	NULL
was	NULL
centrifuged	NULL
to	NULL
remove	NULL
any	NULL
cellular	NULL
debris	NULL
,	NULL
aliquoted	NULL
,	NULL
and	NULL
incubated	NULL
overnight	NULL
at	NULL
4Â°C	NULL
with	NULL
normal	NULL
rabbit	NULL
serum	NULL
as	NULL
the	NULL
control	NULL
serum	NULL
or	NULL
anti-MCP-1	NULL
antiserum	NULL
(	NULL
1:100	NULL
)	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
recovered	NULL
by	NULL
incubation	NULL
with	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
(	NULL
30	NULL
pl	NULL
)	NULL
,	NULL
washed	NULL
five	NULL
times	NULL
with	NULL
immunoprecipitation	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
7.4	NULL
]	NULL
,	NULL
300	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
1	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
10	NULL
mM	NULL
Nal	NULL
)	NULL
plus	NULL
protease	NULL
inhibitors	NULL
,	NULL
washed	NULL
with	NULL
distilled	NULL
water	NULL
,	NULL
and	NULL
then	NULL
eluted	NULL
with	NULL
SDS-PAGE	NULL
sample	NULL
buffer	NULL
(	NULL
2	NULL
%	NULL
SDS	NULL
,	NULL
6	NULL
%	NULL
2-mercaptoethanol	NULL
,	NULL
0.06	NULL
M	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
6.8	NULL
]	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
)	NULL
.	NULL

The	NULL
eluted	NULL
proteins	NULL
were	NULL
boiled	NULL
for	NULL
3	NULL
min	NULL
and	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
on	NULL
17.5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
treated	NULL
with	NULL
Amplify	NULL
(	NULL
Amersham	NULL
Japan	NULL
)	NULL
for	NULL
20	NULL
min	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
XAR	NULL
film	NULL
(	NULL
Eastman	NULL
Kodak	NULL
)	NULL
at	NULL
-70Â°C	NULL
for	NULL
2	NULL
days	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

Confluent	NULL
monolayers	NULL
in	NULL
15-cm-diameter	NULL
dishes	NULL
were	NULL
treated	NULL
with	NULL
test	NULL
samples	NULL
or	NULL
not	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
,	NULL
their	NULL
nuclei	NULL
were	NULL
isolated	NULL
,	NULL
and	NULL
the	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
nuclei	NULL
were	NULL
treated	NULL
with	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
N-2-hydroxyeth-ylpiperazine-N'-2-ethanesulfonic	NULL
acid	NULL
[	NULL
HEPES	NULL
;	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
)	NULL
and	NULL
further	NULL
treated	NULL
by	NULL
being	NULL
stirred	NULL
for	NULL
60	NULL
min	NULL
at	NULL
4Â°C	NULL
in	NULL
buffer	NULL
B	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.42	NULL
M	NULL
NaCl	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
obtained	NULL
by	NULL
centrifugation	NULL
for	NULL
60	NULL
min	NULL
at	NULL
25,000	NULL
x	NULL
g	NULL
and	NULL
desalted	NULL
by	NULL
passage	NULL
through	NULL
a	NULL
Sephadex	NULL
G-25	NULL
column	NULL
equilibrated	NULL
with	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
0.1	NULL
M	NULL
KCI	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
)	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
measured	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Bradford	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

The	NULL
assay	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
binding	NULL
reactions	NULL
were	NULL
performed	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
sample	NULL
protein	NULL
in	NULL
a	NULL
mixture	NULL
of	NULL
2	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
8	NULL
mM	NULL
NaCl	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.8	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
glycerol	NULL
,	NULL
0.2	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
20,000	NULL
cpm	NULL
of	NULL
a	NULL
*Â°P-labeled	NULL
AP-1	NULL
or	NULL
NF-	NULL
Â«	NULL
B	NULL
oligonucleotide	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
20	NULL
pl	NULL
for	NULL
20	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

The	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
tandem	NULL
repeat	NULL
of	NULL
the	NULL
consensus	NULL
sequence	NULL
for	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
AP-1	NULL
,	NULL
-TGACTCA-	NULL
,	NULL
and	NULL
that	NULL
for	NULL
NF-	NULL
Â«	NULL
B	NULL
,	NULL
-GGGGACTITCC-	NULL
,	NULL
was	NULL
end	NULL
labeled	NULL
by	NULL
the	NULL
T4	NULL
polynucleotide	NULL
kinase-	NULL
[	NULL
y-	NULL
``	NULL
``	NULL
PJATP	NULL
method	NULL
.	NULL

Each	NULL
unlabeled	NULL
double-stranded	NULL
oligonucleotide	NULL
was	NULL
used	NULL
as	NULL
a	NULL
competitor	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
were	NULL
electrophoresed	NULL
on	NULL
native	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
0.25	NULL
X	NULL
TBE	NULL
buffer	NULL
(	NULL
22	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
22	NULL
mM	NULL
boric	NULL
acid	NULL
,	NULL
0.6	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

Gels	NULL
were	NULL
vacuumed	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
X-ray	NULL
film	NULL
at	NULL
-70Â°C	NULL
.	NULL

RESULTS	NULL
CD14	NULL
expression	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

Since	NULL
several	NULL
studies	NULL
(	NULL
18	NULL
,	NULL
33	NULL
,	NULL
35	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
are	NULL
P-LPS	NULL
responders	NULL
,	NULL
first	NULL
we	NULL
examined	NULL
,	NULL
using	NULL
anti-human	NULL
CD14	NULL
antibody	NULL
,	NULL
whether	NULL
the	NULL
fibroblasts	NULL
express	NULL
CD14	NULL
.	NULL

Interestingly	NULL
,	NULL
as	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
CD14	NULL
was	NULL
clearly	NULL
detected	NULL
in	NULL
4490	NULL
WATANABE	NULL
ET	NULL
AL	NULL
.	NULL

MCP-1	NULL
#	NULL
e	NULL
0.7	NULL
kbp	NULL
Actin	NULL
|	NULL
P-LPS	NULL
-	NULL
+	NULL
+	NULL
-	NULL
+	NULL
Anti-CD14	NULL
antibody	NULL
-	NULL
-	NULL
;	NULL
4	NULL
-	NULL
Control	NULL
antibody	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
+	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Involvement	NULL
of	NULL
CD14	NULL
in	NULL
MCP-1	NULL
expression	NULL
in	NULL
P-LPS-treated	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
anti-human	NULL
CD14	NULL
antibody	NULL
(	NULL
1:100	NULL
)	NULL
.	NULL

After	NULL
1	NULL
h	NULL
,	NULL
P-LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

was	NULL
added	NULL
,	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
prepared	NULL
6	NULL
h	NULL
thereafter	NULL
.	NULL

Northern	NULL
blotting	NULL
analysis	NULL
was	NULL
performed	NULL
with	NULL
MCP-1	NULL
and	NULL
B-actin	NULL
cDNAs	NULL
used	NULL
as	NULL
probes	NULL
.	NULL

An	NULL
identical	NULL
experiment	NULL
independently	NULL
performed	NULL
gave	NULL
similar	NULL
results	NULL
.	NULL

the	NULL
cells	NULL
.	NULL

This	NULL
immunohistochemical	NULL
observation	NULL
suggests	NULL
the	NULL
possibility	NULL
the	NULL
CD14	NULL
gene	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
examined	NULL
by	NULL
the	NULL
Northern	NULL
blotting	NULL
assay	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
CD14	NULL
gene	NULL
in	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
CD14	NULL
gene	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
cells	NULL
.	NULL

This	NULL
CD14	NULL
expression	NULL
was	NULL
not	NULL
augmented	NULL
by	NULL
P-LPS	NULL
treatment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
looked	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
CD14	NULL
in	NULL
the	NULL
cells	NULL
by	NULL
carrying	NULL
out	NULL
a	NULL
Western	NULL
blotting	NULL
assay	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1D	NULL
,	NULL
the	NULL
presence	NULL
in	NULL
the	NULL
cells	NULL
of	NULL
CD14	NULL
with	NULL
a	NULL
molecular	NULL
mass	NULL
of	NULL
54	NULL
kDa	NULL
was	NULL
confirmed	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
the	NULL
possibility	NULL
that	NULL
P-LPS-mediated	NULL
responses	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
is	NULL
via	NULL
CD14	NULL
.	NULL

Involvement	NULL
of	NULL
CD14	NULL
in	NULL
MCP-1	NULL
gene	NULL
expression	NULL
in	NULL
P-LPS-treated	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
examined	NULL
,	NULL
using	NULL
anti-human	NULL
CD14	NULL
antibody	NULL
,	NULL
whether	NULL
the	NULL
LPS	NULL
induces	NULL
MCP-1	NULL
gene	NULL
expression	NULL
via	NULL
CD14	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
P-LPS-induced	NULL
expression	NULL
of	NULL
the	NULL
MCP-1	NULL
gene	NULL
in	NULL
the	NULL
cells	NULL
was	NULL
markedly	NULL
inhibited	NULL
by	NULL
treatment	NULL
with	NULL
CD14	NULL
antibody	NULL
.	NULL

We	NULL
also	NULL
observed	NULL
that	NULL
P-LPS-induced	NULL
MCP-1	NULL
gene	NULL
expression	NULL
was	NULL
increased	NULL
even	NULL
more	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2	NULL
%	NULL
human	NULL
serum	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
although	NULL
Â£	NULL
.	NULL

coli	NULL
LPS	NULL
was	NULL
not	NULL
able	NULL
to	NULL
induce	NULL
MCP-1	NULL
gene	NULL
expression	NULL
under	NULL
culture	NULL
conditions	NULL
without	NULL
serum	NULL
,	NULL
gene	NULL
expression	NULL
was	NULL
clearly	NULL
induced	NULL
by	NULL
this	NULL
LPS	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2	NULL
%	NULL
serum	NULL
.	NULL

These	NULL
results	NULL
strongly	NULL
indicated	NULL
the	NULL
involvement	NULL
of	NULL
CD14	NULL
in	NULL
P-LPS-induced	NULL
expression	NULL
of	NULL
the	NULL
MCP-1	NULL
gene	NULL
of	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

Therefore	NULL
,	NULL
using	NULL
these	NULL
cells	NULL
as	NULL
an	NULL
experimental	NULL
system	NULL
for	NULL
MCP-1	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
analyzed	NULL
how	NULL
the	NULL
LPS-CD14	NULL
interaction	NULL
leads	NULL
to	NULL
signal	NULL
transduction	NULL
in	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

Effect	NULL
of	NULL
protein	NULL
kinase	NULL
inhibitor	NULL
on	NULL
expression	NULL
of	NULL
the	NULL
MCP-1	NULL
gene	NULL
in	NULL
P-LPS-treated	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

At	NULL
first	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
H-7	NULL
and	NULL
staurosporine	NULL
,	NULL
both	NULL
of	NULL
which	NULL
have	NULL
a	NULL
relatively	NULL
high	NULL
specificity	NULL
for	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
on	NULL
MCP-1	NULL
gene	NULL
expression	NULL
in	NULL
P-LPS-treated	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
one	NULL
of	NULL
the	NULL
inhibitors	NULL
before	NULL
stimulation	NULL
with	NULL
P-LPS	NULL
,	NULL
and	NULL
then	NULL
MCP-1	NULL
gene	NULL
expression	NULL
was	NULL
analyzed	NULL
by	NULL
Northern	NULL
blotting	NULL
assay	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
and	NULL
B	NULL
,	NULL
MCP-1	NULL
gene	NULL
expression	NULL
induced	NULL
by	NULL
P-LPS	NULL
was	NULL
not	NULL
strongly	NULL
affected	NULL
by	NULL
staurosporine	NULL
at	NULL
10	NULL
nM	NULL
or	NULL
by	NULL
H-7	NULL
at	NULL
10	NULL
M.	NULL
We	NULL
also	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
herbimycin	NULL
A	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
tyrosine	NULL
kinase	NULL
,	NULL
on	NULL
expression	NULL
of	NULL
the	NULL
MCP	NULL
gene	NULL
under	NULL
the	NULL
experimental	NULL
conditions	NULL
described	NULL
above	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
the	NULL
inhibitor	NULL
inhibited	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
MCP	NULL
-1	NULL
gene	NULL
expression	NULL
in	NULL
InFECT	NULL
.	NULL

ImnmUN	NULL
.	NULL

the	NULL
cells	NULL
and	NULL
inhibited	NULL
it	NULL
completely	NULL
at	NULL
10	NULL
pg/ml	NULL
.	NULL

The	NULL
inhibitory	NULL
effect	NULL
was	NULL
specific	NULL
,	NULL
because	NULL
B-actin	NULL
gene	NULL
expression	NULL
,	NULL
an	NULL
internal	NULL
control	NULL
,	NULL
was	NULL
unaffected	NULL
by	NULL
the	NULL
inhibitor	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
H-89	NULL
,	NULL
an	NULL
inhibitor	NULL
with	NULL
a	NULL
relatively	NULL
high	NULL
specificity	NULL
for	NULL
protein	NULL
kinase	NULL
A	NULL
,	NULL
on	NULL
MCP-1	NULL
gene	NULL
expression	NULL
was	NULL
examined	NULL
.	NULL

H-89	NULL
at	NULL
25	NULL
M	NULL
barely	NULL
inhibited	NULL
MCP-1	NULL
gene	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
tyrosine	NULL
kinase	NULL
may	NULL
play	NULL
a	NULL
major	NULL
role	NULL
in	NULL
P-LPS-induced	NULL
MCP-1	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

Tyrosine	NULL
kinase	NULL
inhibitor	NULL
inhibits	NULL
MCP-1	NULL
production	NULL
by	NULL
P-LPS-treated	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
herbimycin	NULL
A	NULL
on	NULL
monocyte	NULL
chemotactic	NULL
activity	NULL
in	NULL
the	NULL
culture	NULL
supernatant	NULL
of	NULL
,	NULL
and	NULL
on	NULL
production	NULL
of	NULL
MCP-1	NULL
by	NULL
,	NULL
P-LPS-treated	NULL
cells	NULL
.	NULL

Figure	NULL
5A	NULL
shows	NULL
that	NULL
herbimycin	NULL
A	NULL
inhibited	NULL
the	NULL
chemotactic	NULL
activity	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
observed	NULL
by	NULL
immunoprecipitation	NULL
assay	NULL
that	NULL
the	NULL
inhibitor	NULL
also	NULL
blocked	NULL
MCP-1	NULL
production	NULL
by	NULL
P-LPS-treated	NULL
gingival	NULL
fibroblasts	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
strongly	NULL
suggest	NULL
the	NULL
involvement	NULL
of	NULL
tyrosine	NULL
kinase	NULL
in	NULL
the	NULL
CD14-mediated	NULL
LPS	NULL
signal	NULL
transduction	NULL
for	NULL
MCP-1	NULL
expression	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

Involvement	NULL
of	NULL
transcriptional	NULL
factors	NULL
NF-KB	NULL
and	NULL
AP-1	NULL
in	NULL
expression	NULL
of	NULL
the	NULL
MCP-1	NULL
gene	NULL
in	NULL
P-LPS-treated	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

We	NULL
also	NULL
examined	NULL
,	NULL
using	NULL
potent	NULL
inhibitors	NULL
of	NULL
transcriptional	NULL
factors	NULL
(	NULL
PDTC	NULL
for	NULL
NF-kB	NULL
and	NULL
curcumin	NULL
for	NULL
AP-1	NULL
)	NULL
,	NULL
whether	NULL
either	NULL
or	NULL
both	NULL
factors	NULL
function	NULL
in	NULL
the	NULL
transcription	NULL
of	NULL
MCP-1	NULL
gene	NULL
expression	NULL
in	NULL
P-LPS-treated	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
by	NULL
Northern	NULL
blotting	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
both	NULL
inhibitors	NULL
dose	NULL
dependently	NULL
blocked	NULL
expression	NULL
of	NULL
the	NULL
MCP-1	NULL
gene	NULL
in	NULL
the	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
NF-	NULL
Â«	NULL
B	NULL
and	NULL
AP-1	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
P-LPS-induced	NULL
MCP-1	NULL
gene	NULL
.	NULL

PDTC	NULL
and	NULL
curcumin	NULL
also	NULL
inhibit	NULL
the	NULL
monocyte	NULL
chemotactic	NULL
activity	NULL
of	NULL
P-LPS-treated	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

Since	NULL
MCP-1	NULL
gene	NULL
expression	NULL
of	NULL
P-LPS-treated	NULL
gingival	NULL
fibroblasts	NULL
was	NULL
markedly	NULL
inhibited	NULL
by	NULL
PDTC	NULL
and	NULL
curcumin	NULL
,	NULL
we	NULL
also	NULL
examined	NULL
whether	NULL
both	NULL
inhibitors	NULL
are	NULL
able	NULL
to	NULL
inhibit	NULL
monocyte	NULL
chemotactic	NULL
activity	NULL
in	NULL
culture	NULL
supernatants	NULL
of	NULL
P-LPS-treated	NULL
cells	NULL
.	NULL

Figure	NULL
7	NULL
shows	NULL
that	NULL
the	NULL
chemotactic	NULL
activity	NULL
was	NULL
inhibited	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
by	NULL
both	NULL
inhibitors	NULL
.	NULL

As	NULL
described	NULL
previously	NULL
(	NULL
18	NULL
)	NULL
,	NULL
since	NULL
monocyte	NULL
chemotactic	NULL
activity	NULL
of	NULL
P-LPS-treated	NULL
cells	NULL
almost	NULL
totally	NULL
attributable	NULL
to	NULL
MCP	NULL
the	NULL
marked	NULL
inhibition	NULL
observed	NULL
probably	NULL
resulted	NULL
from	NULL
the	NULL
inhibitory	NULL
ac	NULL
MCP-1	NULL
#	NULL
Actin	NULL
|	NULL
E-LPS	NULL
~	NULL
*+	NULL
Normal	NULL
human	NULL
serum	NULL
-	NULL
+	NULL
+	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

E.	NULL
coli	NULL
LPS-treated	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
augment	NULL
MCP-1	NULL
gene	NULL
expression	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
serum	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
treated	NULL
or	NULL
not	NULL
with	NULL
E.	NULL
coli	NULL
LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
2	NULL
%	NULL
human	NULL
serum	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
prepared	NULL
1	NULL
h	NULL
thereafter	NULL
.	NULL

Northern	NULL
blotting	NULL
analysis	NULL
was	NULL
performed	NULL
with	NULL
MCP-1	NULL
and	NULL
B-actin	NULL
cDNAs	NULL
used	NULL
as	NULL
probes	NULL
.	NULL

An	NULL
identical	NULL
experiment	NULL
independently	NULL
performed	NULL
gave	NULL
similar	NULL
results	NULL
.	NULL

Vou	NULL
.	NULL

64	NULL
,	NULL
1996	NULL
A	NULL
B	NULL
MCP-1	NULL
Â®	NULL
60	NULL
e	NULL
a	NULL
MCP-1	NULL
Actin	NULL
|	NULL
@	NULL
@	NULL
@	NULL
@	NULL
#	NULL
@	NULL
Actin	NULL
P-LPS	NULL
-+	NULL
+	NULL
*+	NULL
+-	NULL
P-LPS	NULL
Staurosporine	NULL
(	NULL
nM	NULL
)	NULL
~	NULL
~-	NULL
9.1	NULL
1	NULL
10	NULL
10	NULL
H7	NULL
CD14-MEDIATED	NULL
SIGNAL	NULL
IN	NULL
GINGIVAL	NULL
FIBROBLASTS	NULL
4491	NULL
C	NULL
@	NULL
Â«	NULL
@	NULL
-	NULL
MCP-1	NULL
e	NULL
e	NULL
@	NULL
ose	NULL
e	NULL
Actin	NULL
|	NULL
@	NULL
@	NULL
@	NULL
@	NULL
ee	NULL
-	NULL
+0	NULL
+	NULL
P-LPS	NULL
=	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+=	NULL
Herbimycin	NULL
A	NULL
-	NULL
-	NULL
0.1	NULL
1	NULL
10	NULL
10	NULL
(	NULL
ng/ml	NULL
)	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
protein	NULL
kinase	NULL
inhibitors	NULL
on	NULL
MCP-1	NULL
expression	NULL
in	NULL
P-LPS-treated	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
staurosporine	NULL
(	NULL
A	NULL
)	NULL
,	NULL
H-7	NULL
at	NULL
10	NULL
wM	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
herbimycin	NULL
A	NULL
(	NULL
C	NULL
)	NULL
.	NULL

After	NULL
1	NULL
h	NULL
,	NULL
P-LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

was	NULL
added	NULL
,	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
prepared	NULL
6	NULL
h	NULL
thereafter	NULL
.	NULL

Northern	NULL
blotting	NULL
analysis	NULL
was	NULL
performed	NULL
with	NULL
MCP-1	NULL
and	NULL
B-actin	NULL
cDNAs	NULL
used	NULL
as	NULL
probes	NULL
.	NULL

An	NULL
identical	NULL
experiment	NULL
independently	NULL
performed	NULL
gave	NULL
similar	NULL
results	NULL
.	NULL

tions	NULL
of	NULL
both	NULL
inhibitors	NULL
on	NULL
MCP-1	NULL
production	NULL
by	NULL
the	NULL
P-LPS-treated	NULL
cells	NULL
.	NULL

P-LPS	NULL
stimulates	NULL
the	NULL
production	NULL
of	NULL
NF-KB	NULL
and	NULL
AP-1	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
prove	NULL
whether	NULL
P-LPS	NULL
actually	NULL
stimulates	NULL
an	NULL
increase	NULL
in	NULL
NF-kB	NULL
and	NULL
AP-1	NULL
contents	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
P-LPS	NULL
on	NULL
NF-	NULL
Â«	NULL
B	NULL
and	NULL
AP-1	NULL
contents	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
by	NULL
conducting	NULL
a	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
P-LPS	NULL
markedly	NULL
stimulated	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
consensus	NULL
sequences	NULL
of	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
AP-1	NULL
and	NULL
NF-	NULL
Â«	NULL
B	NULL
.	NULL

Since	NULL
the	NULL
stimulated	NULL
binding	NULL
in	NULL
each	NULL
case	NULL
was	NULL
completely	NULL
inhibited	NULL
by	NULL
each	NULL
competitor	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
the	NULL
unlabeled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
respective	NULL
consensus	NULL
sequence	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
P-LPS	NULL
is	NULL
able	NULL
to	NULL
stimulate	NULL
an	NULL
increase	NULL
in	NULL
amount	NULL
of	NULL
AP-1	NULL
and	NULL
NF-kB	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

DISCUSSION	NULL
This	NULL
study	NULL
is	NULL
the	NULL
first	NULL
to	NULL
demonstrate	NULL
that	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
express	NULL
CD14	NULL
and	NULL
that	NULL
P-LPS	NULL
induces	NULL
expression	NULL
of	NULL
MCP-1	NULL
in	NULL
the	NULL
cells	NULL
via	NULL
CD14	NULL
.	NULL

Our	NULL
immunohistochemical	NULL
studies	NULL
unexpectedly	NULL
showed	NULL
a	NULL
high	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
CD14	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

This	NULL
observation	NULL
was	NULL
strengthened	NULL
by	NULL
the	NULL
results	NULL
of	NULL
the	NULL
Northern	NULL
and	NULL
Western	NULL
blotting	NULL
assays	NULL
showing	NULL
that	NULL
the	NULL
CD14	NULL
gene	NULL
also	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
cells	NULL
.	NULL

These	NULL
observations	NULL
suggested	NULL
to	NULL
us	NULL
that	NULL
P-LPS	NULL
may	NULL
induce	NULL
expression	NULL
of	NULL
inflammatory	NULL
cytokines	NULL
such	NULL
as	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
MCP-1	NULL
in	NULL
the	NULL
cells	NULL
via	NULL
CD14	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
examined	NULL
,	NULL
using	NULL
anti-human	NULL
CD14	NULL
antibody	NULL
,	NULL
whether	NULL
the	NULL
P-LPS-induced	NULL
MCP-1	NULL
expression	NULL
in	NULL
the	NULL
cells	NULL
is	NULL
mediated	NULL
via	NULL
CD14	NULL
.	NULL

The	NULL
P-LPS	NULL
induction	NULL
was	NULL
dramatically	NULL
inhibited	NULL
by	NULL
the	NULL
antibody	NULL
treatment	NULL
.	NULL

This	NULL
inhibitory	NULL
effect	NULL
proved	NULL
the	NULL
involvement	NULL
of	NULL
CD14	NULL
in	NULL
P-LPS	NULL
induction	NULL
of	NULL
an	NULL
inflammatory	NULL
cytokine	NULL
in	NULL
the	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
previous	NULL
studies	NULL
(	NULL
15	NULL
,	NULL
33	NULL
,	NULL
35	NULL
)	NULL
,	NULL
P-LPS	NULL
is	NULL
able	NULL
to	NULL
induce	NULL
expression	NULL
of	NULL
inflammatory	NULL
cytokines	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
under	NULL
serum-free	NULL
culture	NULL
conditions	NULL
,	NULL
although	NULL
Â£	NULL
.	NULL

coli	NULL
LPS	NULL
did	NULL
not	NULL
have	NULL
such	NULL
an	NULL
effect	NULL
under	NULL
these	NULL
same	NULL
conditions	NULL
.	NULL

The	NULL
reason	NULL
for	NULL
this	NULL
difference	NULL
has	NULL
not	NULL
been	NULL
examined	NULL
in	NULL
detail	NULL
.	NULL

Many	NULL
studies	NULL
(	NULL
4	NULL
,	NULL
11	NULL
,	NULL
29	NULL
,	NULL
40	NULL
)	NULL
have	NULL
suggested	NULL
the	NULL
importance	NULL
of	NULL
LPS-binding	NULL
protein	NULL
(	NULL
LBP	NULL
)	NULL
in	NULL
serum	NULL
for	NULL
the	NULL
LPS	NULL
response	NULL
in	NULL
macrophages	NULL
and	NULL
endothelial	NULL
cells	NULL
,	NULL
because	NULL
the	NULL
LPS	NULL
response	NULL
is	NULL
stimulated	NULL
markedly	NULL
when	NULL
serum	NULL
is	NULL
present	NULL
in	NULL
the	NULL
medium	NULL
.	NULL

An	NULL
interesting	NULL
study	NULL
(	NULL
14	NULL
)	NULL
has	NULL
demonstrated	NULL
that	NULL
LBP	NULL
is	NULL
an	NULL
accelerator	NULL
protein	NULL
for	NULL
LPS	NULL
binding	NULL
to	NULL
CD14	NULL
.	NULL

Interestingly	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
E.	NULL
coli	NULL
LPS	NULL
is	NULL
able	NULL
to	NULL
induce	NULL
expression	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
when	NULL
2	NULL
%	NULL
serum	NULL
is	NULL
present	NULL
in	NULL
the	NULL
B	NULL
A	NULL
100	NULL
200	NULL
%	NULL
80	NULL
97.4â	NULL
>	NULL
Â§	NULL
â¬	NULL
69	NULL
-*	NULL
Â»	NULL
1	NULL
Â§	NULL
so	NULL
46	NULL
-	NULL
Â»	NULL
]	NULL
1	NULL
,	NULL
Fk	NULL
|	NULL
3	NULL
6	NULL
30	NULL
-	NULL
Â»	NULL
**	NULL
;	NULL
I	NULL
<	NULL
3	NULL
40	NULL
Â§	NULL
S	NULL
21.5	NULL
-	NULL
Â»	NULL
=	NULL
3	NULL
20	NULL
smug	NULL
*	NULL
14.3	NULL
_	NULL
a-	NULL
MCP	NULL
P-LPS	NULL
_	NULL
-	NULL
0	NULL
4+	NULL
40	NULL
40	NULL
4+	NULL
=	NULL
i	NULL
Herbimycin	NULL
A	NULL
-	NULL
0.1	NULL
10	NULL
10	NULL
10	NULL
P-LPS	NULL
--	NULL
+	NULL
+	NULL
+	NULL
+	NULL
(	NULL
ug/ml	NULL
)	NULL
Herbimycin	NULL
A	NULL
-	NULL
-	NULL
-	NULL
-	NULL
++	NULL
Control	NULL
serum	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
anti-MCP-	NULL
!	NULL

serum	NULL
+	NULL
-	NULL
+-	NULL
+	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Involvement	NULL
of	NULL
tyrosine	NULL
kinase	NULL
in	NULL
MCP-1	NULL
expression	NULL
in	NULL
P-LPS-treated	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
herbimycin	NULL
A	NULL
.	NULL

After	NULL
1	NULL
h	NULL
,	NULL
P-LPS	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
was	NULL
added	NULL
;	NULL
cell	NULL
culture	NULL
supernatants	NULL
were	NULL
collected	NULL
after	NULL
24	NULL
h.	NULL
Monocyte	NULL
chemotactic	NULL
activity	NULL
in	NULL
the	NULL
supernatant	NULL
was	NULL
measured	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
+	NULL
standard	NULL
deviation	NULL
from	NULL
triplicate	NULL
cultures	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
herbimycin	NULL
A	NULL
at	NULL
10	NULL
pg/ml	NULL
.	NULL

After	NULL
1	NULL
h	NULL
,	NULL
P-LPS	NULL
at	NULL
100	NULL
ng/ml	NULL
was	NULL
added	NULL
,	NULL
and	NULL
then	NULL
the	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
*Â°S	NULL
)	NULL
methionine	NULL
for	NULL
24	NULL
h.	NULL
Finally	NULL
,	NULL
the	NULL
supernatant	NULL
was	NULL
harvested	NULL
and	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
assay	NULL
using	NULL
anti-mouse	NULL
MCP-1	NULL
antiserum	NULL
(	NULL
1:100	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

4492	NULL
WATANABE	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
B	NULL
MCP-1	NULL
Â©	NULL
e	NULL
-	NULL
MCP-1	NULL
Â©e	NULL
&	NULL
e	NULL
Â®	NULL
P-LPS	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+-	NULL
P-LPS	NULL
_	NULL
-	NULL
+	NULL
+	NULL
4	NULL
4	NULL
--	NULL
Curcumin	NULL
(	NULL
uM	NULL
)	NULL
-	NULL
-	NULL
1	NULL
5	NULL
10	NULL
10	NULL
PDTC	NULL
(	NULL
nM	NULL
)	NULL
-	NULL
-	NULL
1	NULL
2	NULL
4	NULL
2	NULL
4	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Involvement	NULL
of	NULL
transcriptional	NULL
factors	NULL
NF-	NULL
Â«	NULL
B	NULL
and	NULL
AP-1	NULL
in	NULL
P-LPS-induced	NULL
MCP-1	NULL
expression	NULL
of	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
curcumin	NULL
(	NULL
A	NULL
)	NULL
or	NULL
PDTC	NULL
(	NULL
B	NULL
)	NULL
.	NULL

After	NULL
1	NULL
h	NULL
,	NULL
P-LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

was	NULL
added	NULL
,	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
prepared	NULL
6	NULL
h	NULL
thereafter	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
with	NULL
MCP-1	NULL
and	NULL
B-actin	NULL
cDNAs	NULL
used	NULL
as	NULL
probes	NULL
.	NULL

An	NULL
identical	NULL
experiment	NULL
independently	NULL
performed	NULL
gave	NULL
similar	NULL
results	NULL
.	NULL

medium	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
,	NULL
though	NULL
the	NULL
LPS	NULL
is	NULL
unable	NULL
to	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
its	NULL
cytokine	NULL
under	NULL
serum-free	NULL
conditions	NULL
as	NULL
described	NULL
above	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
E.	NULL
coli	NULL
LPS	NULL
may	NULL
require	NULL
LBP	NULL
in	NULL
order	NULL
to	NULL
bind	NULL
to	NULL
CD14	NULL
to	NULL
induce	NULL
expression	NULL
of	NULL
cytokines	NULL
of	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

In	NULL
further	NULL
experiments	NULL
,	NULL
it	NULL
will	NULL
be	NULL
important	NULL
to	NULL
elucidate	NULL
this	NULL
point	NULL
.	NULL

We	NULL
(	NULL
18	NULL
)	NULL
previously	NULL
showed	NULL
that	NULL
monocyte	NULL
chemotactic	NULL
activity	NULL
in	NULL
the	NULL
cervical	NULL
fluid	NULL
of	NULL
adult	NULL
periodontal	NULL
patients	NULL
increases	NULL
with	NULL
the	NULL
severity	NULL
of	NULL
the	NULL
disease	NULL
and	NULL
that	NULL
the	NULL
MCP-1	NULL
gene	NULL
is	NULL
expressed	NULL
to	NULL
a	NULL
high	NULL
level	NULL
in	NULL
gingival	NULL
tissues	NULL
of	NULL
patients	NULL
with	NULL
advanced	NULL
disease	NULL
,	NULL
although	NULL
it	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
tissues	NULL
of	NULL
healthy	NULL
subjects	NULL
.	NULL

Several	NULL
investigators	NULL
(	NULL
18	NULL
,	NULL
41	NULL
)	NULL
have	NULL
also	NULL
demonstrated	NULL
that	NULL
MCP	NULL
-1	NULL
gene	NULL
expression	NULL
is	NULL
detectable	NULL
in	NULL
inflamed	NULL
gingiva	NULL
of	NULL
adult	NULL
periodontal	NULL
patients	NULL
.	NULL

These	NULL
observations	NULL
suggested	NULL
an	NULL
important	NULL
role	NULL
for	NULL
MCP-1	NULL
in	NULL
monocyte	NULL
recruitment	NULL
to	NULL
gingival	NULL
tissues	NULL
in	NULL
this	NULL
disease	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
understand	NULL
the	NULL
LPS	NULL
signal-transducing	NULL
pathway	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

Several	NULL
studies	NULL
(	NULL
1	NULL
,	NULL
7	NULL
,	NULL
25	NULL
,	NULL
29	NULL
,	NULL
32	NULL
,	NULL
36	NULL
,	NULL
38	NULL
,	NULL
39	NULL
)	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
LPS	NULL
signal-transducing	NULL
pathway	NULL
in	NULL
monocytes/	NULL
macrophages	NULL
works	NULL
via	NULL
CD14	NULL
.	NULL

As	NULL
described	NULL
above	NULL
,	NULL
since	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
expressed	NULL
CD14	NULL
,	NULL
it	NULL
is	NULL
of	NULL
interest	NULL
to	NULL
understand	NULL
the	NULL
CD14-mediated	NULL
signal	NULL
transducing	NULL
pathway	NULL
,	NULL
A	NULL
100	NULL
-	NULL
80	NULL
3	NULL
5	NULL
60	NULL
5	NULL
5	NULL
ao	NULL
Ã©z	NULL
;	NULL
20	NULL
*~	NULL
3	NULL
0	NULL
P-LPS	NULL
_-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
Curcumin	NULL
(	NULL
uM	NULL
)	NULL
-	NULL
-	NULL
1	NULL
5	NULL
10	NULL
10	NULL
InFECT	NULL
.	NULL

ImnmUN	NULL
.	NULL

because	NULL
such	NULL
a	NULL
pathway	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
demonstrated	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Many	NULL
kinds	NULL
of	NULL
protein	NULL
kinase	NULL
play	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
signal	NULL
transduction	NULL
induced	NULL
by	NULL
LPS	NULL
,	NULL
cytokines	NULL
,	NULL
and	NULL
growth	NULL
factors	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
herbimycin	NULL
A	NULL
,	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
tyrosine	NULL
kinase	NULL
,	NULL
dramatically	NULL
inhibited	NULL
expression	NULL
of	NULL
the	NULL
LPS-induced	NULL
MCP-1	NULL
gene	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

The	NULL
inhibitor	NULL
also	NULL
potently	NULL
inhibited	NULL
monocyte	NULL
chemotactic	NULL
activity	NULL
and	NULL
MCP-1	NULL
production	NULL
in	NULL
culture	NULL
supernatants	NULL
of	NULL
P-LPS-treated	NULL
cells	NULL
.	NULL

Recent	NULL
studies	NULL
(	NULL
1	NULL
,	NULL
5	NULL
,	NULL
7	NULL
,	NULL
17	NULL
,	NULL
25	NULL
,	NULL
30	NULL
,	NULL
32	NULL
,	NULL
36	NULL
,	NULL
38	NULL
,	NULL
39	NULL
)	NULL
also	NULL
have	NULL
shown	NULL
that	NULL
LPS	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
monocytic	NULL
cells	NULL
via	NULL
CD14	NULL
.	NULL

Together	NULL
with	NULL
these	NULL
demonstrations	NULL
,	NULL
our	NULL
study	NULL
suggests	NULL
that	NULL
tyrosine	NULL
kinase	NULL
may	NULL
play	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
signal	NULL
transduction	NULL
in	NULL
LPS-responsive	NULL
fibroblasts	NULL
.	NULL

LPS	NULL
activation	NULL
of	NULL
tyrosine	NULL
kinase	NULL
may	NULL
lead	NULL
to	NULL
formation	NULL
of	NULL
some	NULL
tyrosine-phosphorylated	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
as	NULL
a	NULL
second	NULL
messenger	NULL
.	NULL

We	NULL
do	NULL
not	NULL
know	NULL
which	NULL
tyrosine-phosphorylated	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
is	NULL
induced	NULL
by	NULL
P-LPS	NULL
.	NULL

However	NULL
,	NULL
since	NULL
such	NULL
a	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
induction	NULL
of	NULL
transcriptional	NULL
factors	NULL
that	NULL
regulate	NULL
P-LPS-induced	NULL
responses	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
,	NULL
it	NULL
is	NULL
of	NULL
interest	NULL
to	NULL
identify	NULL
this	NULL
tyrosine-phosphorylated	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
although	NULL
recent	NULL
studies	NULL
(	NULL
16	NULL
,	NULL
26	NULL
)	NULL
have	NULL
demonstrated	NULL
the	NULL
importance	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
in	NULL
LPS-treated	NULL
monocytic	NULL
cells	NULL
,	NULL
we	NULL
do	NULL
not	NULL
know	NULL
whether	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
is	NULL
involved	NULL
in	NULL
P-LPS-treated	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

Our	NULL
next	NULL
interest	NULL
was	NULL
to	NULL
demonstrate	NULL
which	NULL
transcriptional	NULL
factor	NULL
is	NULL
involved	NULL
in	NULL
P-LPS-induced	NULL
MCP	NULL
expression	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

We	NULL
used	NULL
two	NULL
inhibitors	NULL
,	NULL
curcumin	NULL
and	NULL
PDTC	NULL
,	NULL
to	NULL
examine	NULL
this	NULL
point	NULL
.	NULL

Earlier	NULL
studies	NULL
(	NULL
20	NULL
,	NULL
22	NULL
,	NULL
23	NULL
,	NULL
34	NULL
)	NULL
demonstrated	NULL
that	NULL
curcumin	NULL
inhibits	NULL
AP-1	NULL
binding	NULL
to	NULL
the	NULL
consensus	NULL
sequence	NULL
by	NULL
suppressing	NULL
specifically	NULL
the	NULL
c-jun	NULL
gene	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
known	NULL
that	NULL
the	NULL
inhibitor	NULL
is	NULL
also	NULL
able	NULL
to	NULL
inhibit	NULL
NF-kB	NULL
activity	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
PDTC	NULL
inhibits	NULL
NF-	NULL
Â«	NULL
B	NULL
activation	NULL
by	NULL
suppressing	NULL
the	NULL
release	NULL
of	NULL
the	NULL
inhibitory	NULL
subunit	NULL
IxB	NULL
from	NULL
the	NULL
latent	NULL
form	NULL
of	NULL
NF-kB	NULL
(	NULL
28	NULL
)	NULL
.	NULL

We	NULL
observed	NULL
in	NULL
this	NULL
study	NULL
that	NULL
both	NULL
inhibitors	NULL
strongly	NULL
blocked	NULL
expression	NULL
of	NULL
the	NULL
P-LPS-induced	NULL
MCP	NULL
-1	NULL
gene	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

The	NULL
P-LPS-induced	NULL
monocyte	NULL
chemotactic	NULL
activity	NULL
in	NULL
culture	NULL
supernatants	NULL
of	NULL
the	NULL
cells	NULL
also	NULL
was	NULL
drastically	NULL
inhibited	NULL
by	NULL
both	NULL
inhibitors	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
to	NULL
us	NULL
that	NULL
AP-1	NULL
and	NULL
NF-	NULL
Â«	NULL
B	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
P-LPS-induced	NULL
MCP-1	NULL
expression	NULL
.	NULL

Therefore	NULL
,	NULL
using	NULL
the	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
AP-1	NULL
and	NULL
NF-	NULL
Â«	NULL
B	NULL
factors	NULL
are	NULL
induced	NULL
in	NULL
the	NULL
gingival	NULL
fibroblasts	NULL
by	NULL
P-LPS	NULL
.	NULL

The	NULL
gel	NULL
100	NULL
e	NULL
80	NULL
[	NULL
&	NULL
T	NULL
gt	NULL
:	NULL
5	NULL
5	NULL
-	NULL
60	NULL
3	NULL
$	NULL
s	NULL
E	NULL
40	NULL
3	NULL
T	NULL
3	NULL
%	NULL
-	NULL
20	NULL
0	NULL
P-LPS	NULL
-	NULL
+	NULL
+	NULL
+0	NULL
+0	NULL
-o-PDTC	NULL
(	NULL
nM	NULL
)	NULL
-	NULL
-	NULL
1	NULL
2	NULL
4	NULL
20	NULL
4	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Curcumin	NULL
and	NULL
PDTC	NULL
inhibit	NULL
monocyte	NULL
chemotactic	NULL
activity	NULL
in	NULL
culture	NULL
supernatants	NULL
of	NULL
P-LPS-treated	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
curcumin	NULL
(	NULL
A	NULL
)	NULL
or	NULL
PDTC	NULL
(	NULL
B	NULL
)	NULL
.	NULL

After	NULL
1	NULL
h	NULL
,	NULL
P-LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

was	NULL
added	NULL
;	NULL
cell	NULL
culture	NULL
supernatants	NULL
were	NULL
collected	NULL
after	NULL
24	NULL
h.	NULL
Monocyte	NULL
chemotactic	NULL
activity	NULL
in	NULL
each	NULL
supernatant	NULL
was	NULL
measured	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
+	NULL
standard	NULL
deviation	NULL
from	NULL
triplicate	NULL
cultures	NULL
.	NULL

VoL	NULL
.	NULL

64	NULL
,	NULL
1996	NULL
B	NULL
AP-1	NULL
-i-NF-KB	NULL
-	NULL
Â»	NULL
H	NULL
n	NULL
|	NULL
P-LPS	NULL
_-	NULL
+	NULL
P-LPS	NULL
-	NULL
+	NULL
+	NULL
Competitor	NULL
-~	NULL
-	NULL
+	NULL
Competitor	NULL
--	NULL
+	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

P-LPS	NULL
induces	NULL
AP-1	NULL
and	NULL
NF-kB	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
treated	NULL
or	NULL
not	NULL
with	NULL
P-LPS	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
,	NULL
and	NULL
after	NULL
6	NULL
h	NULL
,	NULL
the	NULL
nuclear	NULL
proteins	NULL
were	NULL
prepared	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assay	NULL
was	NULL
performed	NULL
with	NULL
``	NULL
P-labeled	NULL
oligonucleotide	NULL
or	NULL
it	NULL
plus	NULL
,	NULL
as	NULL
the	NULL
competitor	NULL
,	NULL
unlabeled	NULL
oligonucleotide	NULL
(	NULL
10	NULL
ng	NULL
)	NULL
containing	NULL
the	NULL
AP-1	NULL
(	NULL
A	NULL
)	NULL
or	NULL
NF-xB	NULL
(	NULL
B	NULL
)	NULL
consensus	NULL
sequence	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
nuclear	NULL
proteins	NULL
.	NULL

An	NULL
identical	NULL
experiment	NULL
independently	NULL
performed	NULL
gave	NULL
similar	NULL
results	NULL
.	NULL

mobility	NULL
shift	NULL
assay	NULL
showed	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
AP-1	NULL
and	NULL
NF-xB	NULL
contents	NULL
elicited	NULL
by	NULL
the	NULL
P-LPS	NULL
.	NULL

Since	NULL
this	NULL
increase	NULL
was	NULL
blocked	NULL
completely	NULL
by	NULL
each	NULL
competitor	NULL
,	NULL
an	NULL
unlabeled	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
AP-1	NULL
or	NULL
NF-kB	NULL
consensus	NULL
sequence	NULL
,	NULL
the	NULL
P-LPS-induced	NULL
AP-1	NULL
and	NULL
NF-	NULL
Â«	NULL
B	NULL
increase	NULL
is	NULL
spe-cific	NULL
.	NULL

Recently	NULL
,	NULL
negative	NULL
and	NULL
positive	NULL
regulation	NULL
among	NULL
transcriptional	NULL
factors	NULL
have	NULL
been	NULL
proposed	NULL
by	NULL
many	NULL
investigators	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
the	NULL
near	NULL
future	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
demonstrate	NULL
the	NULL
type	NULL
of	NULL
regulation	NULL
effected	NULL
by	NULL
transcriptional	NULL
factors	NULL
involved	NULL
in	NULL
P-LPS-induced	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
P-LPS	NULL
induces	NULL
activation	NULL
of	NULL
tyrosine	NULL
kinase	NULL
in	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
via	NULL
CD14	NULL
,	NULL
which	NULL
leads	NULL
to	NULL
MCP-1	NULL
gene	NULL
expression	NULL
through	NULL
transcriptional	NULL
factors	NULL
AP-1	NULL
and	NULL
NF-xB	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
T.	NULL
Umemoto	NULL
,	NULL
Kanagawa	NULL
Dental	NULL
College	NULL
,	NULL
for	NULL
providing	NULL
the	NULL
P-LPS	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
S.	NULL
Yamamoto	NULL
,	NULL
Oita	NULL
Medical	NULL
University	NULL
,	NULL
for	NULL
his	NULL
gift	NULL
of	NULL
mouse	NULL
CD14	NULL
cDNA	NULL
probe	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
thank	NULL
B.	NULL
J.	NULL
Rollins	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
for	NULL
sending	NULL
us	NULL
the	NULL
MCP	NULL
-1	NULL
cDNA	NULL
probe	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
J.	NULL
Ohno	NULL
for	NULL
helping	NULL
with	NULL
the	NULL
immunohistochemical	NULL
tests	NULL
.	NULL

REFERENCES	NULL
.	NULL

Arditi	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Zhou	NULL
,	NULL
M.	NULL
Torres	NULL
,	NULL
D.	NULL
L.	NULL
Durden	NULL
,	NULL
M.	NULL
Stins	NULL
,	NULL
and	NULL
K.	NULL
S.	NULL
Kim	NULL
.	NULL

1996	NULL
.	NULL

Lipopolysaccharide	NULL
stimulates	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
p44	NULL
,	NULL
p42	NULL
,	NULL
and	NULL
p41	NULL
in	NULL
vascular	NULL
endothelial	NULL
cells	NULL
in	NULL
a	NULL
soluble	NULL
CD14-dependent	NULL
manner	NULL
.	NULL

Role	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
lipopolysaccharide-induced	NULL
stimulation	NULL
of	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:3994-4003.	NULL
.	NULL

Bom-van	NULL
Noorloos	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
J.	NULL
W.	NULL
M.	NULL
van	NULL
der	NULL
Meer	NULL
,	NULL
J.	NULL
S.	NULL
van	NULL
de	NULL
Gevel	NULL
,	NULL
E.	NULL
Schepens	NULL
,	NULL
T.	NULL
J.	NULL
M.	NULL
van	NULL
Steebergen	NULL
,	NULL
and	NULL
E.	NULL
H.	NULL
Burger	NULL
.	NULL

1990	NULL
.	NULL

Bacteroides	NULL
gingivalis	NULL
stimulates	NULL
bone	NULL
resorption	NULL
via	NULL
interleukin-1	NULL
production	NULL
by	NULL
mononuclear	NULL
cells	NULL
.	NULL

The	NULL
relative	NULL
role	NULL
for	NULL
B.	NULL
gingivalis	NULL
endotoxin	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Periodon-tol	NULL
.	NULL

17:409-413	NULL
.	NULL

3	NULL
.	NULL

Bradford	NULL
,	NULL
M.	NULL
M.	NULL
1976	NULL
.	NULL

A	NULL
rapid	NULL
and	NULL
sensitive	NULL
method	NULL
for	NULL
the	NULL
quantitation	NULL
of	NULL
protein	NULL
utilizing	NULL
the	NULL
principle	NULL
of	NULL
protein-dye	NULL
binding	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

72	NULL
:	NULL
248-254.	NULL
.	NULL

Camussi	NULL
,	NULL
G.	NULL
,	NULL
F.	NULL
Mariano	NULL
,	NULL
L.	NULL
Biancone	NULL
,	NULL
A	NULL
.	NULL

De	NULL
Martino	NULL
,	NULL
B.	NULL
Bussolati	NULL
,	NULL
G.	NULL
Montrucchio	NULL
,	NULL
and	NULL
P.	NULL
S.	NULL
Tobias	NULL
.	NULL

1995	NULL
.	NULL

Lipopolysaccharide	NULL
binding	NULL
protein	NULL
and	NULL
CD14	NULL
modulate	NULL
the	NULL
synthesis	NULL
of	NULL
platelet-activating	NULL
factor	NULL
by	NULL
human	NULL
monocytes	NULL
and	NULL
mesangial	NULL
and	NULL
endothelial	NULL
cells	NULL
stimulated	NULL
with	NULL
lipopolysaccharide	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:316-324	NULL
.	NULL

5	NULL
.	NULL

Chamnugam	NULL
,	NULL
P.	NULL
,	NULL
L.	NULL
Feng	NULL
,	NULL
S.	NULL
Liou	NULL
,	NULL
B.	NULL
C.	NULL
Jang	NULL
,	NULL
M.	NULL
Boudreau	NULL
,	NULL
G.	NULL
Yu	NULL
,	NULL
J.	NULL
H.	NULL
Lee	NULL
,	NULL
H.	NULL
J.	NULL
Kwon	NULL
,	NULL
T.	NULL
Beppu	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
Y.	NULL
Xia	NULL
,	NULL
C.	NULL
B.	NULL
Wilson	NULL
,	NULL
and	NULL
D.	NULL
Hwang	NULL
.	NULL

1995	NULL
.	NULL

Radicicol	NULL
,	NULL
a	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
,	NULL
suppresses	NULL
the	NULL
expression	NULL
of	NULL
mitogen-inducible	NULL
cyclooxygenase	NULL
in	NULL
macrophages	NULL
stimulated	NULL
with	NULL
lipopoly-	NULL
b	NULL
m	NULL
CD14-MEDIATED	NULL
SIGNAL	NULL
IN	NULL
GINGIVAL	NULL
FIBROBLASTS	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

4493	NULL
saccharide	NULL
and	NULL
in	NULL
experimental	NULL
glomerulonephritis	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:6418-6426.	NULL
.	NULL

Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
A.	NULL
,	NULL
A.	NULL
E.	NULL
Przbyla	NULL
,	NULL
R.	NULL
J.	NULL
MacDonald	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Rutter	NULL
.	NULL

1979	NULL
.	NULL

Isolation	NULL
of	NULL
biologically	NULL
active	NULL
ribonucleic	NULL
acid	NULL
from	NULL
sources	NULL
enriched	NULL
in	NULL
ribonuclease	NULL
.	NULL

Biochemistry	NULL
18:6296-6299.	NULL
.	NULL

Delude	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
M.	NULL
J.	NULL
Fenton	NULL
,	NULL
R.	NULL
Savedra	NULL
,	NULL
Jr.	NULL
,	NULL
P.	NULL
Y.	NULL
Perera	NULL
,	NULL
S.	NULL
N.	NULL
Vogel	NULL
,	NULL
R.	NULL
Thieringer	NULL
,	NULL
and	NULL
D.	NULL
T.	NULL
Golenbock	NULL
.	NULL

1994	NULL
.	NULL

CD14-mediated	NULL
translocation	NULL
of	NULL
nuclear	NULL
factor-kB	NULL
induced	NULL
by	NULL
lipopolysaccharide	NULL
does	NULL
not	NULL
require	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:22263-22260.	NULL
.	NULL

Dong	NULL
,	NULL
Z.	NULL
,	NULL
X.	NULL
Qi	NULL
,	NULL
and	NULL
I.	NULL
J.	NULL
Fidler	NULL
.	NULL

1993	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
mitogen-	NULL
activated	NULL
protein	NULL
kinases	NULL
is	NULL
necessary	NULL
for	NULL
activation	NULL
of	NULL
murine	NULL
macrophages	NULL
by	NULL
natural	NULL
and	NULL
synthetic	NULL
bacterial	NULL
products	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

177:1071-1077.	NULL
.	NULL

Falk	NULL
,	NULL
W.	NULL
,	NULL
R.	NULL
H.	NULL
J.	NULL
Goodwin	NULL
,	NULL
and	NULL
E.	NULL
J.	NULL
Leonard	NULL
.	NULL

1980	NULL
.	NULL

A	NULL
48-well	NULL
microche-	NULL
motaxis	NULL
assembly	NULL
for	NULL
rapid	NULL
and	NULL
accurate	NULL
measurement	NULL
of	NULL
leukocyte	NULL
migra-tion	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
33:293-247	NULL
.	NULL

Fearns	NULL
,	NULL
C.	NULL
,	NULL
V.	NULL
V.	NULL
Kraychenko	NULL
,	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
,	NULL
and	NULL
D.	NULL
J.	NULL
Loskutof	NULL
.	NULL

1996	NULL
.	NULL

Murine	NULL
CD14	NULL
gene	NULL
expression	NULL
in	NULL
vivo	NULL
:	NULL
extramyeloid	NULL
synthesis	NULL
and	NULL
regulation	NULL
by	NULL
lipopolysaccharide	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:857-866	NULL
.	NULL

Gegner	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
,	NULL
and	NULL
P.	NULL
S.	NULL
Tobias	NULL
.	NULL

1996	NULL
.	NULL

Lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
signal	NULL
transduction	NULL
and	NULL
clearance	NULL
.	NULL

Dual	NULL
roles	NULL
for	NULL
LPS	NULL
binding	NULL
protein	NULL
and	NULL
membrane	NULL
CD14	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:6320-6326	NULL
.	NULL

Gemmell	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Seymour	NULL
.	NULL

1993	NULL
.	NULL

Interleukin-1	NULL
,	NULL
interleukin-6	NULL
and	NULL
transforming	NULL
growth	NULL
factor-B	NULL
production	NULL
by	NULL
human	NULL
gingival	NULL
mononuclear	NULL
cells	NULL
following	NULL
stimulation	NULL
with	NULL
Porphyromonas	NULL
gingivalis	NULL
and	NULL
Fusobacterium	NULL
nucleatum	NULL
.	NULL

J.	NULL
Periodontal	NULL
Res	NULL
.	NULL

28:122-129	NULL
.	NULL

Genco	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
J	NULL
.	NULL

Slots	NULL
.	NULL

1984	NULL
.	NULL

Host	NULL
responses	NULL
in	NULL
periodontal	NULL
diseases	NULL
.	NULL

J.	NULL
Dent	NULL
.	NULL

Res	NULL
.	NULL

63:441-451	NULL
.	NULL

Hailman	NULL
,	NULL
E.	NULL
,	NULL
H.	NULL
S.	NULL
Lichenstein	NULL
,	NULL
M.	NULL
M.	NULL
Wurfel	NULL
,	NULL
D.	NULL
S.	NULL
Miller	NULL
,	NULL
D.	NULL
A.	NULL
Johnson	NULL
,	NULL
M.	NULL
Kelley	NULL
,	NULL
L.	NULL
A.	NULL
Busse	NULL
,	NULL
M.	NULL
M.	NULL
Zukowski	NULL
,	NULL
and	NULL
S.	NULL
D.	NULL
Wright	NULL
.	NULL

1994	NULL
.	NULL

Lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
-binding	NULL
protein	NULL
accelerates	NULL
the	NULL
binding	NULL
of	NULL
LPS	NULL
to	NULL
CD14	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179:269-277	NULL
.	NULL

Hamada	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Takada	NULL
,	NULL
T.	NULL
Ogawa	NULL
,	NULL
T.	NULL
Fujiwara	NULL
,	NULL
and	NULL
J.	NULL
Mihara	NULL
.	NULL

1990	NULL
.	NULL

Lipopolysaccharides	NULL
of	NULL
oral	NULL
anaerobes	NULL
associated	NULL
with	NULL
chronic	NULL
inflammation	NULL
:	NULL
chemical	NULL
and	NULL
immunomodulating	NULL
properties	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

6:247-261	NULL
.	NULL

Hambleton	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
McMahon	NULL
,	NULL
and	NULL
A.	NULL
L.	NULL
DeFranco	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
Raf-1	NULL
and	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
in	NULL
murine	NULL
macrophages	NULL
partially	NULL
mimics	NULL
lipopolysaccharide-induced	NULL
signaling	NULL
events	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182:147-154	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
D.	NULL
Lee	NULL
,	NULL
P.	NULL
S.	NULL
Tobias	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
.	NULL

1993	NULL
.	NULL

Endotoxin	NULL
induces	NULL
rapid	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
70Z/3	NULL
cells	NULL
expressing	NULL
CD14	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:25009-25014	NULL
.	NULL

Hanazawa	NULL
,	NULL
S.	NULL
,	NULL
Y.	NULL
Kawata	NULL
,	NULL
A.	NULL
Takeshita	NULL
,	NULL
H.	NULL
Kumada	NULL
,	NULL
M.	NULL
Okithu	NULL
,	NULL
S.	NULL
Tanaka	NULL
,	NULL
Y.	NULL
Yamamoto	NULL
,	NULL
T.	NULL
Masuda	NULL
,	NULL
T.	NULL
Umemoto	NULL
,	NULL
and	NULL
S.	NULL
Kitano	NULL
.	NULL

1993	NULL
.	NULL

Expression	NULL
of	NULL
monocyte	NULL
chemoattractant	NULL
protein	NULL
1	NULL
(	NULL
MCP-1	NULL
)	NULL
in	NULL
adult	NULL
periodontal	NULL
disease	NULL
:	NULL
increased	NULL
monocyte	NULL
chemotactic	NULL
activity	NULL
in	NULL
crevicular	NULL
fluids	NULL
and	NULL
induction	NULL
of	NULL
MCP-1	NULL
expression	NULL
in	NULL
gingival	NULL
tissues	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

61:5219-5224	NULL
.	NULL

Hanazawa	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
Takeshita	NULL
,	NULL
S.	NULL
Amano	NULL
,	NULL
T.	NULL
Semba	NULL
,	NULL
T.	NULL
Nirazuka	NULL
,	NULL
H.	NULL
Katoh	NULL
,	NULL
and	NULL
S.	NULL
Kitano	NULL
.	NULL

1993	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor-	NULL
Â«	NULL
induces	NULL
expression	NULL
of	NULL
monocyte	NULL
chemoattractant	NULL
JE	NULL
via	NULL
fos	NULL
and	NULL
jun	NULL
genes	NULL
in	NULL
clonal	NULL
osteoblastic	NULL
MC3T3-E1	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:9526-9532	NULL
.	NULL

Hanazawa	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
Takeshita	NULL
,	NULL
and	NULL
S.	NULL
Kitano	NULL
.	NULL

1994	NULL
.	NULL

Retinoic	NULL
acid	NULL
suppression	NULL
of	NULL
c-fos	NULL
gene	NULL
inhibits	NULL
expression	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
Â«	NULL
induced	NULL
monocyte	NULL
chemoattractant	NULL
JE/MCP-1	NULL
in	NULL
clonal	NULL
osteoblastic	NULL
MC3T3-E1	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:21379-21384	NULL
.	NULL

Haziot	NULL
,	NULL
A.	NULL
,	NULL
B	NULL
.	NULL

Z.	NULL
Tsuberi	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Goyert	NULL
.	NULL

1993	NULL
.	NULL

Neutrophil	NULL
CD14	NULL
:	NULL
biochemical	NULL
properties	NULL
and	NULL
role	NULL
in	NULL
the	NULL
secretion	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
Â«	NULL
in	NULL
response	NULL
to	NULL
lipopolysaccharide	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:5556-5565	NULL
.	NULL

Hirofumi	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Okazaki	NULL
,	NULL
H.	NULL
Yamamoto	NULL
,	NULL
H.	NULL
Okano	NULL
,	NULL
Y.	NULL
Takeda	NULL
,	NULL
M.	NULL
Tashima	NULL
,	NULL
H.	NULL
Sawada	NULL
,	NULL
M.	NULL
Okuma	NULL
,	NULL
H.	NULL
Ishikura	NULL
,	NULL
H.	NULL
Umehara	NULL
,	NULL
and	NULL
N.	NULL
Domae	NULL
.	NULL

1995	NULL
.	NULL

Requirement	NULL
of	NULL
AP-1	NULL
for	NULL
ceramide-induced	NULL
apoptosis	NULL
in	NULL
human	NULL
leukemia	NULL
HL-60	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:27326-27331	NULL
.	NULL

Huang	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
S.	NULL
C.	NULL
Lee	NULL
,	NULL
and	NULL
J.	NULL
K.	NULL
Lin	NULL
.	NULL

1991	NULL
.	NULL

Suppression	NULL
of	NULL
c-Jun/AP-1	NULL
activation	NULL
by	NULL
an	NULL
inhibitor	NULL
of	NULL
tumor	NULL
promotion	NULL
in	NULL
mouse	NULL
fibroblast	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:5292-5296	NULL
.	NULL

Kumada	NULL
,	NULL
H.	NULL
,	NULL
Y.	NULL
Haishima	NULL
,	NULL
T.	NULL
Umemoto	NULL
,	NULL
and	NULL
K.	NULL
Tanamoto	NULL
.	NULL

1995	NULL
.	NULL

Structural	NULL
study	NULL
on	NULL
the	NULL
free	NULL
lipid	NULL
A	NULL
isolated	NULL
from	NULL
lipopolysaccharide	NULL
of	NULL
Porphyromonas	NULL
gingivalis	NULL
.	NULL

J.	NULL
Bacteriol	NULL
.	NULL

177:2098-2106.	NULL
.	NULL

LeGrand	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
and	NULL
R.	NULL
Thieringer	NULL
.	NULL

1994	NULL
.	NULL

CD14-dependent	NULL
induction	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
by	NULL
lipopolysaccharide	NULL
in	NULL
murine	NULL
B-lym-phoma	NULL
cells	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1223:36-46	NULL
.	NULL

Liu	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
P.	NULL
Herrera	NULL
Velit	NULL
,	NULL
R.	NULL
W.	NULL
Brownsey	NULL
,	NULL
and	NULL
N.	NULL
E.	NULL
Reiner	NULL
.	NULL

1994	NULL
.	NULL

CD14-dependent	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
(	NULL
p42	NULL
and	NULL
p44	NULL
)	NULL
in	NULL
human	NULL
monocytes	NULL
treated	NULL
with	NULL
bacterial	NULL
lipopolysaccharide	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:2642-2652	NULL
.	NULL

Maniatis	NULL
,	NULL
T.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
J.	NULL
Sambrook	NULL
.	NULL

1982	NULL
.	NULL

Molecular	NULL
cloning	NULL
:	NULL
a	NULL
laboratory	NULL
manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
B.	NULL
Meier	NULL
,	NULL
D.	NULL
N.	NULL
Mannel	NULL
,	NULL
W.	NULL
Droge	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1992	NULL
.	NULL

Dithiocardamates	NULL
as	NULL
potent	NULL
inhibitors	NULL
of	NULL
nuclear	NULL
factor	NULL
B	NULL
activation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:1181-1194	NULL
.	NULL

Shapira	NULL
,	NULL
L.	NULL
,	NULL
C.	NULL
Champagne	NULL
,	NULL
B.	NULL
Gordon	NULL
,	NULL
S.	NULL
Amar	NULL
,	NULL
and	NULL
T.	NULL
E.	NULL
Van-Dyke	NULL
.	NULL

1995	NULL
.	NULL

Lipopolysaccharide	NULL
priming	NULL
of	NULL
superoxide	NULL
release	NULL
by	NULL
human	NULL
neutrophils	NULL
:	NULL
4494	NULL
30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

WATANABE	NULL
ET	NULL
AL	NULL
.	NULL

role	NULL
of	NULL
membrane	NULL
CD14	NULL
and	NULL
serum	NULL
LPS	NULL
binding	NULL
protein	NULL
.	NULL

Inflammation	NULL
19:289-295	NULL
.	NULL

Shapira	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Takashiba	NULL
,	NULL
C.	NULL
Champagne	NULL
,	NULL
S.	NULL
Amar	NULL
,	NULL
and	NULL
T.	NULL
E.	NULL
Van	NULL
Dyke	NULL
.	NULL

1994	NULL
.	NULL

Involvement	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
in	NULL
lipopolysaccharide-induced	NULL
TNF-	NULL
Â«	NULL
and	NULL
IL-16	NULL
production	NULL
by	NULL
human	NULL
monocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:1818-1824	NULL
.	NULL

Sismey-Durrant	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Hopps	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
lipopolysaccharide	NULL
from	NULL
the	NULL
oral	NULL
bacterium	NULL
Bacteroides	NULL
gingivalis	NULL
on	NULL
osteoclastic	NULL
resorption	NULL
of	NULL
sperm-whale	NULL
dentine	NULL
slices	NULL
in	NULL
vitro	NULL
.	NULL

Arch	NULL
.	NULL

Oral	NULL
Biol	NULL
.	NULL

32:911-913	NULL
.	NULL

Stefanova	NULL
,	NULL
L	NULL
,	NULL
M.	NULL
L.	NULL
Corcoran	NULL
,	NULL
E.	NULL
M.	NULL
Horak	NULL
,	NULL
L.	NULL
M.	NULL
Wabl	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Bolen	NULL
,	NULL
and	NULL
I.	NULL
D.	NULL
Horak	NULL
.	NULL

1993	NULL
.	NULL

Lipopolysaccharide	NULL
induces	NULL
activation	NULL
of	NULL
CD14-associated	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
p53/561yn	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:20725-20728	NULL
.	NULL

Takada	NULL
,	NULL
H.	NULL
,	NULL
J.	NULL
Mihara	NULL
,	NULL
I	NULL
Morisaki	NULL
,	NULL
and	NULL
S.	NULL
Hamada	NULL
.	NULL

1991	NULL
.	NULL

Induction	NULL
of	NULL
interleukin-1	NULL
and	NULL
-6	NULL
in	NULL
human	NULL
gingival	NULL
fibroblast	NULL
cultures	NULL
stimulated	NULL
with	NULL
Bacteroides	NULL
lipopolysaccharides	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

59:295-301	NULL
.	NULL

Takeshita	NULL
,	NULL
A.	NULL
,	NULL
Y.	NULL
Chen	NULL
,	NULL
A.	NULL
Watanabe	NULL
,	NULL
S.	NULL
Kitano	NULL
,	NULL
and	NULL
S.	NULL
Hanazawa	NULL
.	NULL

1995	NULL
.	NULL

TGF-B	NULL
induces	NULL
expression	NULL
of	NULL
monocyte	NULL
chemoattractant	NULL
JE/monocyte	NULL
chemoattractant	NULL
protein	NULL
1	NULL
via	NULL
transcriptional	NULL
factor	NULL
AP-1	NULL
induced	NULL
by	NULL
protein	NULL
kinase	NULL
in	NULL
osteoblastic	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:419-426	NULL
.	NULL

Tamura	NULL
,	NULL
L.	NULL
,	NULL
M.	NULL
Tokuda	NULL
,	NULL
S.	NULL
Nagaoka	NULL
,	NULL
and	NULL
H.	NULL
Takada	NULL
.	NULL

1992	NULL
.	NULL

Lipopolysaccharides	NULL
of	NULL
Bacteroides	NULL
intermedius	NULL
(	NULL
Prevotella	NULL
intermedia	NULL
)	NULL
and	NULL
Bacteroides	NULL
(	NULL
Por-phyromonas	NULL
)	NULL
gingivalis	NULL
induce	NULL
interleukin-8	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
gin	NULL
Editor	NULL
:	NULL
J.	NULL
R.	NULL
McGhee	NULL
36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

InFECT	NULL
.	NULL

ImnmUN	NULL
.	NULL

gival	NULL
fibroblast	NULL
cultures	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

60:4932-4937	NULL
.	NULL

Ternisien	NULL
,	NULL
C.	NULL
,	NULL
V.	NULL
Ollivier	NULL
,	NULL
F.	NULL
Khechai	NULL
,	NULL
M.	NULL
Ramani	NULL
,	NULL
J.	NULL
Hakim	NULL
,	NULL
and	NULL
D.	NULL
de	NULL
Prost	NULL
.	NULL

1995	NULL
.	NULL

Protein	NULL
tyrosine	NULL
kinase	NULL
activation	NULL
is	NULL
required	NULL
for	NULL
LPS	NULL
and	NULL
PMA	NULL
induction	NULL
of	NULL
tissue	NULL
factor	NULL
mRNA	NULL
in	NULL
human	NULL
blood	NULL
monocytes	NULL
.	NULL

Thromb	NULL
.	NULL

Hae-mostasis	NULL
73:413-420	NULL
.	NULL

Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

1993	NULL
.	NULL

Recognition	NULL
of	NULL
bacterial	NULL
endotoxins	NULL
by	NULL
receptor-depen-dent	NULL
mechanisms	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

53:267-289	NULL
.	NULL

Weinstein	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
and	NULL
A.	NULL
L.	NULL
DeFranco	NULL
.	NULL

1993	NULL
.	NULL

Lipopolysaccharide-induced	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
human	NULL
macrophages	NULL
is	NULL
mediated	NULL
by	NULL
CD14	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:3829-3838	NULL
.	NULL

Weinstein	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
J.	NULL
S.	NULL
Sanghera	NULL
,	NULL
K.	NULL
Lemke	NULL
,	NULL
A.	NULL
L.	NULL
DeFranco	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Pelech	NULL
.	NULL

1992	NULL
.	NULL

Bacterial	NULL
lipopolysaccharide	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
in	NULL
macrophages	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:14955-14962	NULL
.	NULL

Wright	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
R.	NULL
A.	NULL
Ramos	NULL
,	NULL
P.	NULL
S.	NULL
Tobias	NULL
,	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Mathison	NULL
.	NULL

1990	NULL
.	NULL

CD14	NULL
,	NULL
a	NULL
receptor	NULL
for	NULL
complexes	NULL
of	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
and	NULL
LPS	NULL
binding	NULL
protein	NULL
.	NULL

Science	NULL
249:1431-1433	NULL
.	NULL

Yu	NULL
,	NULL
X.	NULL
,	NULL
H.	NULL
N.	NULL
Antoniades	NULL
,	NULL
and	NULL
D.	NULL
T.	NULL
Graves	NULL
.	NULL

1993	NULL
.	NULL

Expression	NULL
of	NULL
monocyte	NULL
chemoattractant	NULL
protein	NULL
1	NULL
in	NULL
human	NULL
inflamed	NULL
gingival	NULL
tissues	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

61:4622-4628	NULL
.	NULL

Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
.	NULL

1993	NULL
.	NULL

CD14	NULL
:	NULL
cell	NULL
surface	NULL
receptor	NULL
and	NULL
differentiation	NULL
marker	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
14:121-125	NULL
.	NULL

